IQVIA Holdings Inc. (IQV)

Market Cap	27.24B -1.5%
Revenue (ttm)	16.31B +5.9%
Net Income	1.36B -0.9%
EPS	7.84 +4.7%
Shares Out	167.87M
PE Ratio	20.70
Forward PE	12.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,087,271
Open	161.33
Previous Close	160.68
Day's Range	160.20 - 164.13
52-Week Range	134.65 - 247.05
Beta	1.39
Analysts	Strong Buy
Price Target	227.13 (+39.96%)
Earnings Date	May 5, 2026

About IQV

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 9, 2013
• Employees: 93,000
• Stock Exchange: NYSE
• Ticker Symbol: IQV
• Website: https://www.iqvia.com

Financial Performance

In 2025, IQVIA Holdings's revenue was $16.31 billion, an increase of 5.87% compared to the previous year's $15.41 billion. Earnings were $1.36 billion, a decrease of -0.95%.

Analyst Summary

According to 16 analysts, the average rating for IQV stock is "Strong Buy." The 12-month stock price target is $227.13, which is an increase of 39.96% from the latest price.

Price Target

$227.13

(39.96% upside)

Analyst Consensus: Strong Buy